Key terms
About OGN
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest OGN news
Apr 08
6:09am ET
Organon, Shanghai Henlius Biotech: Phase 3 study of HLX14 met primary endpoints
Feb 27
1:01am ET
Organon & Co. Is Worried About This – Should You Be Worried Too?
Feb 16
9:20am ET
Analysts Offer Insights on Healthcare Companies: Organon (OGN) and Sarepta Therapeutics (SRPT)
Feb 16
7:38am ET
Piper Sandler Remains a Buy on Organon (OGN)
Feb 16
5:31am ET
Organon price target raised to $26 from $25 at Barclays
Feb 16
5:21am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sanofi (OtherSNYNF), Laboratory (LH) and Organon (OGN)
Feb 16
5:11am ET
Maintaining Sell Rating on Organon: Short-Term Gains Overshadowed by Long-Term Strategy Concerns
Feb 15
8:02am ET
Organon Reports Quarterly and Annual Financial Results
Feb 15
7:38am ET
Organon sees FY24 revenue $6.2B-$6.5B, consensus $6.41B
Feb 15
7:36am ET
Organon reports Q4 adjusted EPS 88c, consensus 83c
No recent press releases are available for OGN
OGN Financials
Key terms
Ad Feedback
OGN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
OGN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
